Navigation Links
Genzyme Reports Strong Second-Quarter Growth
Date:7/23/2008

/p>

services sold $(6,311) $(300,330)

Selling, general and

administrative $(31,904) $(347,305)

Research and development $(175,000) $(16,092) $(381,861)

Amortization of intangibles $(55,605) $(55,605)

Purchase of in-process

research and development $-

Equity in income (loss) of

equity method investments $-

Minority interest $563

Gains (losses) on

investments in equity

securities $9,153

Other $19

Investment income $13,352

Interest expense $(1,149)

Summary:

Income (loss) before income

taxes $(175,000) $(55,605) $(54,307) $107,971

(Provision for) benefit

from income taxes $33,749 $29,615 $16,834 $(38,407)

Net income (loss) $(141,251) $(25,990) $(37,473) $69,564

Net income (loss) per share:

Basic $(0.53) $(0.10) $(0.14) $0.26

Diluted (1) $(0.50) $(0.09) $(0.13) $0.25

Weighted average shares

outstanding:

Basic 266,904

Diluted (1) 284,262

(1) GAAP As-Reported diluted earnings per share and diluted weighted

average shares outstanding reflect the adoption of EITF 04-8. In

accordance with the provisions of EITF 04-8, interest and debt fee
'/>"/>

SOURCE Genzyme Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. Novel Angiogenic Drugs, Including a Future Blockbuster from Genzyme, Could Revolutionize Treatment of Peripheral Arterial Disease
2. Genzyme Begins Major Expansion of Boston Manufacturing Facility
3. Genzyme Affirms Purchase Price for Bioenvision at $5.60 Per Outstanding Share
4. Genzyme Receives Approval to Market Elaprase(R) in Japan
5. Genzyme Recognized by Scientists as a Top Employer
6. Genzyme to Participate in FDA Advisory Committee Meeting on the Use of Phosphate Binders in Chronic Kidney Disease
7. FDA Approves Genzymes Renvela(TM) for Dialysis Patients
8. Genzyme Launches Cholestagel(R) in Europe
9. BioVex Appoints Genzyme Executive, Jan van Heek, as Chairman of the Board of Directors
10. Genzyme and Sunway to Collaborate on Gene Therapy Program in China
11. Genzyme Study of Myozyme(R) for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Hungary , September 30, 2014 ... and intuitive browsing of chemistry in documents ... chemistry software solutions and consulting services for life ... chemical information and generate Markush structures from documents. ... an organizations intellectual property, however generating and understanding ...
(Date:9/30/2014)... 30, 2014 OriginOil Inc. (OTC/QB: OOIL), ... process to clean up large quantities of water, announced ... Eckelberry reported on the launch of the company's CLEAN-FRAC™ ... provided by partner STW Resources . , Immediately ... per day (bpd) and achieved a 99.8% reduction in ...
(Date:9/30/2014)... 30, 2014 BioHealth Innovation, Inc. ... biohealth innovations and increasing access to early-stage funding in ... venture capitalist, Tania Fernandez , Ph.D., has joined ... will be a member of the management team for ... to $50 million in seed and early-stage equity investments ...
(Date:9/30/2014)... iLab Solutions announced the results of its ... focuses on core facility operations, growth and utilization as ... , In its 4th year running, a number of ... year-over-year decrease in the percentage of revenue that comes ... the constraints of this trend. When asked, “What are ...
Breaking Biology Technology:ChemAxon Introduces ChemCurator for Chemical Information Extraction and Markush Structure Creation 2OriginOil, Inc. Report to Shareholders: Blue Gold in West Texas 2Seasoned Life Sciences Venture Capitalist Tania Fernandez Joins BHI to Help Manage New BioHealth Gap Fund 2iLab Solutions Announces the Results of the 2014 Core Facility Benchmarking Study 2iLab Solutions Announces the Results of the 2014 Core Facility Benchmarking Study 3
... RainDance Technologies, Inc., a privately held provider ... disease research, today announced it will be shipping ... and reviewed the company,s opportunities for growth at ... initial application of the company,s RainStorm(TM) microdroplet-based technology ...
... and CEO of Cryo-Cell International and C,elle(SM), Welcomes President ... As the CEO of Cryo-Cell International, the nation,s most ... been an active participant in the stem cell and ... the changes that have taken place over the past ...
... Biotech, an Advanced Instruments company, will introduce its ... which delivers faster cycle times, a touch screen ... and efficiency in microbiology laboratories -- at The ... May, 2009."The introduction of the new Autoplate represents ...
Cached Biology Technology:RainDance Technologies Reviews Opportunities for Growth at Cowen Health Care Conference 2RainDance Technologies Reviews Opportunities for Growth at Cowen Health Care Conference 3Stem Cell Industry Insider Mercedes Walton Discusses President Obama's Stem Cell Executive Order 2Stem Cell Industry Insider Mercedes Walton Discusses President Obama's Stem Cell Executive Order 3Spiral Biotech to Introduce New Autoplate Spiral Plating System at ASM General Meeting in May 2Spiral Biotech to Introduce New Autoplate Spiral Plating System at ASM General Meeting in May 3
(Date:9/30/2014)... --- Do we think of nature as something that we ... need to "preserve?" Or do we think of ourselves as ... of nature, but what about a house? , The ... also reflected in our actions, our speech and in cultural ... the University of Washington, the American Indian Center of Chicago ...
(Date:9/30/2014)... do seedless watermelon, salmon, and strawberries all have in ... two sets of chromosomes and are diploid, these organisms ... sets of chromosomesseedless watermelon and salmon have 3 and ... While this might seem surprising, in fact most ... first discovered over a century ago, but only recently, ...
(Date:9/30/2014)... The National Institutes of Health (NIH) awarded ... to develop an electrode array system that will ... works through unprecedented resolution and scale. , LLNL,s ... support President Obama,s BRAIN (Brain Research through ... effort to revolutionize our understanding of the human ...
Breaking Biology News(10 mins):The cultural side of science communication 2Gene doubling shapes the world: Instant speciation, biodiversity, and the root of our existence 2Gene doubling shapes the world: Instant speciation, biodiversity, and the root of our existence 3Gene doubling shapes the world: Instant speciation, biodiversity, and the root of our existence 4NIH taps lab to develop sophisticated electrode array system to monitor brain act 2NIH taps lab to develop sophisticated electrode array system to monitor brain act 3
... having a child and attending university may be subconsciously influenced ... a Queen,s University study. "Life expectancy might be driving ... doctoral fellow in the Queen,s math department who has a ... to live, the more time they will invest in education. ...
... drink blood and spread disease such as river blindnesscreating misery ... that the pesky insects can be useful. Don Champagne, ... Environmental Sciences, discovered a way to use the black fly,s ... were published in the journal PLoS One . ...
... nanoparticles to convert laser energy into "plasmonic nanobubbles," researchers ... Cancer Center and Baylor College of Medicine (BCM) are ... directly into cancer cells. In tests on drug-resistant cancer ... nanobubbles was up to 30 times more deadly to ...
Cached Biology News:Black flies may have a purpose after all 2Black flies may have a purpose after all 3'Nanobubbles' plus chemotherapy equals single-cell cancer targeting 2'Nanobubbles' plus chemotherapy equals single-cell cancer targeting 3'Nanobubbles' plus chemotherapy equals single-cell cancer targeting 4
Rabbit polyclonal to LCAT ( Abpromise for all tested applications). entrezGeneID: 3931 SwissProtID: P04180...
Mouse monoclonal [7E10] to C Peptide ( Abpromise for all tested applications). entrezGeneID: 3630 SwissProtID: P01308...
... transporter 2 (APT2) (Peptide ... PSF2) (Peptide supply factor ... involved in antigen processing ... Antigen: Recombinant ...
This monoclonal antibody recognizes the light chain of human Factor XII and at 100 nM inhibits 50% of Factor XII activity. It may be used in ELISA to detect human Factor XII and in coagulation assay...
Biology Products: